Literature DB >> 18423499

No somatic mutations detected in the Mad2 gene in 658 human tumors.

D A Ruddy1, B Gorbatcheva, G Yarbrough, R Schlegel, J E Monahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18423499     DOI： 10.1016/j.mrfmmm.2008.02.008

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  3 in total

1.  Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin.

Authors:  Li Wang; Fang Yin; Yulei Du; Bei Chen; Shuhui Liang; Yongguo Zhang; Wenqi Du; Kaichun Wu; Jie Ding; Daiming Fan
Journal:  Tumour Biol       Date:  2010-05-04

2.  Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.

Authors:  Mahesh Tambe; Sofia Pruikkonen; Jenni Mäki-Jouppila; Ping Chen; Bente Vilming Elgaaen; Anne Hege Straume; Kaisa Huhtinen; Olli Cárpen; Per Eystein Lønning; Ben Davidson; Sampsa Hautaniemi; Marko J Kallio
Journal:  Oncotarget       Date:  2016-03-15

3.  MAD2 Combined with Mitotic Spindle Apparatus (MSA) and Anticentromere Antibody (ACA) for Diagnosis of Small Cell Lung Cancer (SCLC).

Authors:  Yang Wu; Liming Tan; Juanjuan Chen; Hua Li; Houqun Ying; Yongqing Jiang; Qiong Wu; Guofang Yu; Yongjian Tian; Jianlin Yu; Tingting Zeng; Linxian Yan; Chuan Liu
Journal:  Med Sci Monit       Date:  2018-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.